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Background
IVIg is a polyclonal IgG preparation with potent
immune-modulating properties. We demonstrated that
IVIg protects against airway hyperreactivity (AHR) and
airway inflammation in mouse models of allergic airway
disease, accompanied by peripheral induction of Foxp3
+regulatory T-cells (iTreg). The requirement of IVIg-
induced iTreg and their antigen-specificity in attenuation
of AHR and airway inflammation remains unknown.
Methods
We utilized DEREG mice, carrying a transgenic
diphtheria toxin receptor under the control of the Foxp3
promoter, allowing for selective depletion of Foxp3+Treg
by the application of diphtheria toxin (DT). Mice were
sensitized and challenged with ovalbumin (OVA) and
treated with IVIg. AHR was measured using a FlexiVent
small animal ventilator. Total and antigen-specific IgE,
as well as pro-inflammatory cytokines levels were
determined in serum and alveolar lavage, using ELISA.
Results
In the absence of Treg, due to multiple DT doses before
and after the treatment, IVIg was not able to attenuate
AHR, diminish IgE levels and Th-2 type cytokine produc-
tion, nor alleviate airway inflammation. However, mice in
which the pre-established Treg cells (nTreg) were depleted
before but not following IVIg treatment demonstrated an
induction of Foxp3+Treg to IVIg therapy and did not
develop AHR and airway inflammation to allergen-
challenge. Adoptive transfer of enriched IVIg-induced
iTreg from OVA-IVIg treated mice failed to transfer
protection to mice exposed to ragweed, but was protective
in OVA-sensitized and challenged mice.
Conclusions
Treg can be induced from effector CD4
+T-cells in the
absence of nTreg. IVIg-induced antigen specific Treg are
capable of suppressing all aspects of antigen-driven airway
inflammation in an antigen-specific manner.
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